No time to breathe easy as the battle against asthma intensifies
Asthma is one of those conditions that can strike the very young and stay with them as they head into old age, often developing over many years into the more serious illness Chronic Obstructive...
Acesis breaks new ground with novel therapy solution to low testosterone
For the first time in over 70 years, a new testosterone replacement therapy has been unveiled. Dr Vassilios Papadopoulos and Dr Costas Karatzas, co-founders of Acesis BioMed, explain how their ‘first-in-class’ peptide therapeutics could...
Look into my eyes – and learn!
The average octopus may be shy and retiring - but they do know how to pull a party trick! Whether swimming by jet propulsion, blasting inky chemicals at enemies, or changing skin to blend...
Biotech pioneer tackles the biology of ageing
Living to a ripe old age is one thing. Enjoying a healthy, ripe old age is the challenge. Biotech veteran Dr Eric Leire aims to slow ageing by design, as he explains to Karen...
AI used to improve cardiovascular risk prediction
AI startup Owkin and Amgen have announced the results of a three-year project using artificial intelligence to more accurately predict cardiovascular risk. This study demonstrates the ability of AI to improve the way that...
Robust, ready-to-use cell-based potency assays for biosimilar development
By Jane Lamerdin, Ph.D., Abhishek Saharia, Ph. D.
DiscoveRx Corporation, Fremont, CA 94538, USA
Biosimilars are defined as drugs that are “highly similar” to or “interchangeable” with an approved biologic. The lack of a clearly defined...
Next-generation biologics: today’s reality
Shark molecules provide the basis of unique new therapeutics which could transform the treatment of inflammatory diseases and cancer. Karen Southern talks to Dr Caroline Barelle, CEO and founder of Elasmogen, the small biopharmaceutical...
The UK’s first dedicated Vaccines Manufacturing Innovation Centre
The world class centre that will give the UK sovereign resilience and a global platform in the fight against Covid and many other diseases besides.
The Vaccines Manufacturing and Innovation Centre, a not-for-profit organisation established...
Find out why County Durham’s NETPark is quickly becoming a global hub for bio-science...
Home to two UK catapult centres, three national innovation centres and one of the country’s leading AIM listed tech companies, The North East Technology Park (NETPark) really is a thriving hub of innovation making...
HOPE ON THE HORIZON FOR ALZHEIMER’S TREATMENT
Dr Susan Kohlhaas
Director of Research at Alzheimer’s Research UK
People with dementia have been disproportionately affected by the COVID-19 pandemic. In fact, according to the ONS, a quarter of people who have died from COVID-19...
Product Characterization for Cell Therapy GMP Manufacturing
The specifications, QC and release testing of cell therapy products can make the difference between success and failure
Stefanos Theoharis, Suncana Kern and Christine Guenther, apceth GmbH & Co. KG. All manufactured products require measurable parameters,...
MenB – RIP
The UK Department of Health has announced that it will work to introduce the meningococcal B (MenB) vaccine into the childhood vaccination programme – But to what impact?
Officials made the announcement following independent advice...
Opening new pathways for bioprocessing
A pivotal link between industry and academia, Teesside University’s £22m National Horizons Centre (NHC) opened last September with two very clear objectives.
One is to drive research into bioprocessing, an often-overlooked subject through which life...
Precision breeding for a sustainable future: unpacking the future of genomics
Neil Ward, General Manager of PacBio EMEA, examines the potential impact of the UK’s Precision Breeding Bill.
Genomic sequencing holds the potential to unlock powerful insights that will advance our understanding of all life. In...
Putting the diverse into neurodiversity
The global Institute Of Neurodiversity ION has launched its UK chapter.
The Institute aims to give a global voice to all neurodiverse groups, and ensure neurodivergent individuals are understood, represented, and valued equally in society.
Currently, 1 in...
WEAPONISING THE FIGHT AGAINST ANTIBIOTIC RESISTANCE
Could faecal transplants be an effective weapon in the fight back against antibiotic resistance? A research team at Guy’s and St Thomas’ NHS Foundation Trust intends to find out, once and for all.
By HELEN...